SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-059455
Filing Date
2021-12-07
Accepted
2021-12-06 17:35:50
Documents
12
Period of Report
2021-12-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20211206.htm   iXBRL 8-K 27729
  Complete submission text file 0001564590-21-059455.txt   155657

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20211206.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20211206_lab.xml EX-101.LAB 19337
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20211206_pre.xml EX-101.PRE 11497
5 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-8k_20211206_htm.xml XML 3561
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 211474081
SIC: 2834 Pharmaceutical Preparations